Takara Bio Group Formulated “Medium-Term Management Plan 2026”
Takara Bio Group Formulated “Medium-Term Management Plan 2026” | IR News | News Release ＆ IR News | Investor Relations Read more
Tag: Takara
Notice Concerning Dividends from Surplus
Notice Concerning Dividends from Surplus | IR News | News Release ＆ IR News | Investor Relations Read more
ARTICLES OF INCORPORATION
ARTICLES OF INCORPORATION | IR News | News Release ＆ IR News | Investor Relations Read more
Consolidated Financial Results for the Nine Months Ended December 31, 2022（Under Japanese GAA）
Consolidated Financial Results for the Nine Months Ended December 31, 2022（Under Japanese GAA） | IR News | News Release ＆ IR News | Investor Relations Read more
[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product
[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product | IR News | News Release ＆ IR News | Investor Relations Read more
Notice Concerning Revisions to the First Half Financial Results Forecasts
Notice Concerning Revisions to the First Half Financial Results Forecasts | IR News | News Release ＆ IR News | Investor Relations Read more
Notice of Dividends of Surplus
Notice of Dividends of Surplus | IR News | News Release ＆ IR News | Investor Relations Read more
Consolidated Financial Statements for the Year Ended March 31, 2022 FY2022 (April 1, 2021 – March 31, 2022) [UNAUDITED]
Consolidated Financial Statements for the Year Ended March 31, 2022 FY2022 (April 1, 2021 – March 31, 2022) [UNAUDITED] | IR News | News Release ＆ IR News | Investor Relations Read more
Takara Bio Report 2020
Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relations Japanese... Read more
Consolidated Financial Statements for the Second Quarter Ended September 30, 2020 FY2021 (April 1, 2020 – September 30, 2020) [UNAUDITED]
Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese... Read more